BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27583690)

  • 1. Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Aug; 38(8):423-4. PubMed ID: 27583690
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Melo MA; Carvalho JS; Feitosa FE; Araujo Júnior E; Peixoto AB; Costa Carvalho FH; Carvalho RC
    Rev Bras Ginecol Obstet; 2016 Jun; 38(6):308-13. PubMed ID: 27399926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment On: Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Triebel J; Clapp C; Bertsch T
    Rev Bras Ginecol Obstet; 2016 Nov; 38(11):580-582. PubMed ID: 27875851
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Prolactin Inhibition in the Treatment of Peripartum Cardiomyopathy.
    Fett JD
    Rev Bras Ginecol Obstet; 2016 Sep; 38(9):477-478. PubMed ID: 27658008
    [No Abstract]   [Full Text] [Related]  

  • 5. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
    de Jong JS; Rietveld K; van Lochem LT; Bouma BJ
    Eur J Heart Fail; 2009 Feb; 11(2):220-2. PubMed ID: 19168522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump.
    Schroeter MR; Unsöld B; Holke K; Schillinger W
    Clin Res Cardiol; 2013 Feb; 102(2):155-7. PubMed ID: 22829017
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of Subsequent Pregnancy After Recovery From Peripartum Cardiomyopathy.
    Elkayam U
    J Am Coll Cardiol; 2023 Jul; 82(1):27-29. PubMed ID: 37380300
    [No Abstract]   [Full Text] [Related]  

  • 9. Promoting awareness of peripartum cardiomyopathy (PPCM).
    Fett JD
    Int J Cardiol; 2020 Apr; 305():113-114. PubMed ID: 32035690
    [No Abstract]   [Full Text] [Related]  

  • 10. What Should Be Generalized Diagnostic Markers for Peripartum Cardiomyopathy?
    Sakuma I; Anzai T
    Circ J; 2017 Oct; 81(11):1578-1579. PubMed ID: 29021419
    [No Abstract]   [Full Text] [Related]  

  • 11. Imbalanced Angiogenesis in Peripartum Cardiomyopathy (PPCM).
    Damp JA; Arany Z; Fett JD; Blauwet L; Elkayam U
    Circ J; 2018 Sep; 82(10):2689. PubMed ID: 30122728
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the association between hypertensive disorders of pregnancy and peripartum cardiomyopathy.
    Kolte D
    Eur J Heart Fail; 2017 Dec; 19(12):1721-1722. PubMed ID: 28891239
    [No Abstract]   [Full Text] [Related]  

  • 13. Devil in Disguise: Hints and Pitfalls in Diagnosis of Peripartum Cardiomyopathy.
    Bauersachs J; Koenig T
    Circ Heart Fail; 2018 Apr; 11(4):e004620. PubMed ID: 29626100
    [No Abstract]   [Full Text] [Related]  

  • 14. [Succès de traitement par Cabergoline d'une série de cas de cardiomyopathie du péripartum, incluant un cas critique nécessitant une assistance circulatoire mécanique].
    Hamdan R; Abdallah Y; Gafar S; ElSaeidi E; Kadri Z; Al Nooryani A
    Ann Cardiol Angeiol (Paris); 2023 Oct; 72(4):101610. PubMed ID: 37300904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripartum cardiomyopathy for the clinician: the known and the unknown.
    Elkayam U
    Eur J Heart Fail; 2017 Sep; 19(9):1142-1144. PubMed ID: 28653358
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart Failure and Pregnancy: Thinking Beyond Peripartum Cardiomyopathy.
    Lindley KJ
    J Card Fail; 2021 Feb; 27(2):153-156. PubMed ID: 33573757
    [No Abstract]   [Full Text] [Related]  

  • 17. 12‑lead ECG as an emerging risk stratifier in peripartum cardiomyopathy.
    Tak BT; Cetin EHO; Ulvan N; Cay S; Aras D
    Int J Cardiol; 2019 Oct; 293():185. PubMed ID: 31447034
    [No Abstract]   [Full Text] [Related]  

  • 18. Coincidence of peripartum cardiomyopathy and systemic lupus erythematosus.
    Niklas K; Niklas A; Puszczewicz M; Radziemski A; Tykarski A
    Kardiol Pol; 2016; 74(2):194. PubMed ID: 27150565
    [No Abstract]   [Full Text] [Related]  

  • 19. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
    Arrigo M; Blet A; Mebazaa A
    Eur Heart J; 2017 Sep; 38(35):2680-2682. PubMed ID: 28934838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patient with sudden cardiac arrest, peripartum cardiomyopathy and pulmonary embolism].
    Lewandowski A; Syska-Sumińska J; Załęska-Zydlewska I; Grzywanowska-Łaniewska I; Wsól A; Dłużniewski M
    Kardiol Pol; 2013; 71(7):741-3. PubMed ID: 23907909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.